Sivia Lapidus, M.D., Pediatric Rheumatologist, Joseph M. Sanzari Children’s Hospital, Hackensack Meridian Health
Assistant Professor of Pediatrics, Hackensack Meridian School of Medicine Faculty at the Center for Discovery and Innovation Hearst Foundation Physician Scientist
Guest Researcher, National Human Genome Research Institute, National Institutes of Health
Leader of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Autoinflammatory/Periodic Fever Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Work Group
Dr. Lapidus has been drawn to clinical care and translational research in autoinflammatory diseases since her post graduate training under the mentorship of Dr. Daniel Kastner, the founder of autoinflammation, at the National Institutes of Health.
As a pediatric rheumatologist who cares for rare and debilitating inflammatory conditions, she strives to find solutions to achieve optimum therapeutics through targeting dysregulated inflammation. As the inaugural Hearst Foundation Physician Scientist, her research interrogates the pathogenesis, therapeutics, and genetics of autoinflammatory disease with a focus on PFAPA. As the leader of the Childhood Arthritis Rheumatology Research Alliance’s Autoinflammatory Work Group, the group is working towards supporting infrastructure for advancing translational research in autoinflammatory diseases in North America. Since May 2020, Dr. Sivia Lapidus has been the leader of the task force of the Hackensack Meridian Health Network dedicated to optimizing treatment, care, and research for MIS-C. Additionally, she has been a member of the American College of Rheumatology MIS-C Task Force where she contributed to generating guidance for the care of patients who are suspected of having MIS-C as well as other COVID-related hyperinflammatory conditions. Through her long-term mission of pursuing translational science at HMH, Dr. Lapidus primarily hopes to improve treatment and earlier diagnoses in inflammatory conditions affecting children.